RxDoctor Payments Data

Randy Bullock, APRN

Nurse Practitioner · Ogden, UTNPI 1528099231

Payments from drug & device makers

$475in general payments, 2019–2025

Across 25 payments — averaging $18.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$128
  • Indivior Inc.$98
  • Alkermes, Inc.$67
  • Teva Pharmaceuticals USA, Inc.$44
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$33
  • Braeburn Inc.$25
  • plus $81 from 5 others

What the payments were for

  • Food & beverage$475100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$475 in reported general payments places this provider in the 65th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$17,696
Medicare patients
75
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate264$753,088
Risperdal ConstaRisperidone Microspheres157$167,521
AristadaAripiprazole Lauroxil29$47,612
Risperidone ErRisperidone Microspheres51$47,573
VraylarCariprazine Hcl25$35,458
Clozapine242$10,998
AuvelityDextromethorphan Hbr/Bupropion11$10,120
Olanzapine OdtOlanzapine38$7,145
TrintellixVortioxetine Hydrobromide11$5,066
Aripiprazole139$5,010
Olanzapine205$3,983
Paliperidone ErPaliperidone15$3,061
Quetiapine Fumarate191$3,031
Duloxetine Hcl139$2,956
Atomoxetine Hcl28$2,250

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Risperdal Consta$17$920,610421 claims
Alkermes, Inc.Aristada$67$47,61229 claims
Teva Pharmaceuticals USA, Inc.Loxapine$44$1,71216 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 979 nurse practitioner providers in Utah.

Other nurse practitioner in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →